Lung

Zinc has been found to be important in reducing lung infections in people with cystic fibrosis, whose immune cells' natural bacteria-fighting ability has been reduced by the genetic mutation that causes the disease.

Improving the health of the gut microbiome by way of fecal transplant or dietary modification has been shown to noticeably improve COPD symptoms, opening the door to microbiome-targeted treatments for this currently incurable condition.

New research has proved for the first time that RSV infection, common in young children, can penetrate nerve cells and may lead to nerve damage. The findings underscore the possible long-term effects of RSV and the importance of preventive measures.

A new study has found the BA.2.86 variant of SARS-CoV-2 has a greater propensity for infecting certain lung cells than any prior Omicron variant. The research suggests BA.2.86 could potentially lead to COVID severity similar to the Delta variant.

Researchers have used human cells to create tiny biobots that can encourage healing in damaged neurons without requiring genetic modifications. The tiny bots have the potential to transform regenerative medicine and the treatment of disease.

A study has found that a protein that normally triggers our immune system to defend against certain viruses plays a pivotal role in exacerbating COPD. The unexpected discovery may lead to new therapeutic approaches for the incurable condition.

A study has found that non-COVID respiratory infections can lead to ‘long’ symptoms that persist well beyond the acute infection stage. The findings increase awareness about the existence of long-lasting respiratory infections other than long COVID.

Even moderate exposure to nicotine-free vapor from e-cigarettes can literally stop the body's frontline immune cells in their tracks, reducing their ability to fight off foreign invaders, a new study has found.

Researchers have discovered that lung-based immune cells can be "trained" to remember a previously encountered pathogen, making them more efficient at clearing out the cellular debris that accumulates during infection and reducing inflammation.

A group of US and Canadian anesthesiologists has sounded the alarm on the new class of weight-loss drugs, this time warning that they can increase the risk of serious complications for patients under sedation on the operating table.

A new study suggests that people with low levels of vitamin K in their blood are more likely to have reduced lung function and to report lung problems like asthma, chronic obstructive pulmonary disease (COPD), or wheezing.

Researchers have developed an inhalable drug that targets the overactive white blood cells that cause lung damage during severe infection. With clinical trials due next year, it may soon be a novel treatment for COVID complications and pneumonia.